Acadian Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-19,747
Closed -$956K – 2243
2025
Q4
$956K Buy
+19,747
New +$979K ﹤0.01% 1126
2023
Q1
– Sell
-874
Closed -$42K – 1957
2022
Q4
$42K Hold
874
– – ﹤0.01% 1602
2022
Q3
$33K Buy
874
+547
+167% +$24.4K ﹤0.01% 1550
2022
Q2
$16K Hold
327
– – ﹤0.01% 1629
2022
Q1
$16K Buy
+327
New +$16.9K ﹤0.01% 1584
2021
Q3
– Sell
-3,142
Closed -$165K – 1993
2021
Q2
$165K Buy
+3,142
New +$164K ﹤0.01% 1497

Other funds holding SNY

Acadian Asset Management's SNY Position: Q1 2026 in Review

Acadian Asset Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 19,747 shares — an estimated $956K sold.

Acadian Asset Management first reported a position in SNY in Q2 2021 and held it in 6 quarters. The position peaked at $956K in Q4 2025. 746 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Acadian Asset Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 19,747 Sanofi shares in Q1 2026, an estimated $956K.
  • Acadian Asset Management first reported a position in Sanofi in Q2 2021 and held it in 6 quarters.
  • Acadian Asset Management's Sanofi position peaked at $956K in Q4 2025.
  • 746 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.